LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2935 | 3486 | 0.8418 | 0.7894 |
MDA-MB-231 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 868 | 1291 | 3486 | 0.3705 | 0.1618 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2804 | 3486 | 0.8045 | 0.7396 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 868 | 3425 | 3486 | 0.9826 | 0.9768 |
MDA-MB-231 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3172 | 3486 | 0.9099 | 0.8801 |
MDA-MB-231 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 868 | 3383 | 3486 | 0.9705 | 0.9608 |
MDA-MB-231 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 868 | 3735 | 3486 | 1.0714 | 1.0951 |
MDA-MB-231 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 868 | 946 | 3486 | 0.2714 | 0.0299 |
MDA-MB-231 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 868 | 830 | 3486 | 0.2381 | -0.0146 |
MDA-MB-231 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2799 | 3486 | 0.8029 | 0.7376 |
MDA-MB-231 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 868 | 2625 | 3486 | 0.7531 | 0.6713 |
MDA-MB-231 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3685 | 3486 | 1.0570 | 1.0759 |
MDA-MB-231 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2779 | 3486 | 0.7971 | 0.7298 |
MDA-MB-231 | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2674 | 3486 | 0.7672 | 0.6900 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 736 | 3486 | 0.2113 | -0.0502 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 868 | 581 | 3486 | 0.1668 | -0.1094 |
MDA-MB-231 | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2408 | 3486 | 0.6907 | 0.5881 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 868 | 3419 | 3486 | 0.9807 | 0.9743 |
MDA-MB-231 | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 3174 | 3486 | 0.9105 | 0.8808 |
MDA-MB-231 | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 2270 | 3486 | 0.6511 | 0.5354 |
MDA-MB-231 | R406 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3202 | 3486 | 0.9184 | 0.8914 |
MDA-MB-231 | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 868 | 2611 | 3486 | 0.7491 | 0.6659 |
MDA-MB-231 | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 868 | 3934 | 3486 | 1.1284 | 1.1710 |
MDA-MB-231 | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 868 | 1081 | 3486 | 0.3103 | 0.0816 |
MDA-MB-231 | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 868 | 1227 | 3486 | 0.3519 | 0.1371 |